Tenet Healthcare beats by $0.22, reports revs in-line; guides Q4 EPS below consensus, revs below consensus; also authorizes a $1 bln share repurchase program
- Reports Q3 (Sep) earnings of $1.44 per share, excluding non-recurring items, $0.22 better than the S&P Capital IQ Consensus of $1.22; revenues fell 1.9% year/year to $4.8 bln vs the $4.8 bln S&P Capital IQ Consensus.
- Co issues downside guidance for Q4, sees EPS of $1.00-1.54, excluding non-recurring items, vs. $1.77 S&P Capital IQ Consensus; sees Q4 revs of $4.816-$5.016 bln vs. $5.04 bln S&P Capital IQ Consensus.
- Co also authorizes a $1 bln share repurchase program.
No comments:
Post a Comment